HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arwa S Kathiria Selected Research

NAD (NADH)

5/2013Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arwa S Kathiria Research Topics

Disease

2Inflammation (Inflammations)
05/2013 - 11/2012
2Colitis
05/2013 - 11/2012
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2013 - 01/2012
1Leukemia
12/2019
1Neoplasm Metastasis (Metastasis)
10/2017
1Carcinogenesis
11/2012

Drug/Important Bio-Agent (IBA)

3Transcription Factors (Transcription Factor)IBA
12/2019 - 05/2013
3ProhibitinsIBA
05/2013 - 01/2012
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2013 - 01/2012
1ChromatinIBA
12/2019
1quinone (benzoquinone)IBA
05/2013
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
05/2013
1villinIBA
05/2013
1sym-trinitrobenzeneIBA
05/2013
1AntioxidantsIBA
05/2013
1Dextrans (Dextran)FDA Link
05/2013
1NAD (NADH)IBA
05/2013
1Sulfonic AcidsIBA
05/2013
1Mitochondrial Proteins (Mitochondrial Protein)IBA
05/2013
1Heme Oxygenase-1IBA
05/2013
1Proteins (Proteins, Gene)FDA Link
11/2012
1Oxidants (Oxidizing Agents)IBA
01/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012
1CytokinesIBA
01/2012